Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAD Therapy in Relapsed/Refractory Multiple Myeloma
NCT00814541Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Dec 2005
- Primary completion
- Jun 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Cancer Trials Ireland. Started Dec 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00814541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814541.